Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies

Valentin Feichtenschlager(Cancer Research Institute), Susana Ortiz-Urda(Cancer Research Institute)

Communications Medicine

June 5, 2025

10.1038/s43856-025-00932-5

Cited by 2

Related Papers

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

|Molecular Cancer|2024|14

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

|Research Square|2023|1